For instance, it enhances the expression of CXCR6 in Group 3 innate lymphoid cells and promotes their liver homing mediated by the CXCL16/CXCR6 axis, leading to increased IL-22 secretion and reduced hepatic steatosis[179]. Here, CXCR6 is linked to fatty liver disease.